Ask Warren

HLB Pharmaceutical

047920 · KOSDAQ · ₩047920 · HLB제약

₩9,500▼ ₩10 (0.11%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩62B₩66B₩63B₩61B₩47B₩35B₩33B₩35B
Cost of sales₩35B₩36B₩33B₩32B₩23B₩10B₩13B₩12B
Gross profit₩27B₩30B₩30B₩28B₩24B₩24B₩20B₩23B
Operating income−₩31M₩1B₩835M₩34M−₩1.8B₩2B−₩1.2B₩855M
Net income−₩57M₩720M₩2.3B−₩161M₩910M₩1.6B₩2.2B₩948M
Net income to shareholders−₩57M₩720M₩2.3B−₩161M₩910M₩1.6B₩2.2B₩948M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩178B₩203B₩171B₩168B₩163B₩145B₩158B₩160B
Current assets₩78B₩77B₩77B₩83B₩80B₩60B₩63B₩82B
Cash and equivalents₩4.5B₩4.3B₩7.6B₩8.4B₩6.7B₩8.7B₩10B₩15B
Total liabilities₩47B₩51B₩46B₩47B₩40B₩35B₩42B₩41B
Current liabilities₩41B₩41B₩40B₩43B₩38B₩33B₩39B₩35B
Borrowings₩15B₩15B₩15B₩15B₩15B₩15B₩15B₩15B
Total equity₩131B₩152B₩125B₩121B₩123B₩109B₩116B₩119B
Shareholders' equity₩131B₩152B₩125B₩121B₩123B₩109B₩116B₩119B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩775M₩587M₩1.1B₩1.9B−₩1.3B−₩1.1B₩567M₩849M
Capital spending₩1B₩2.8B₩2.5B₩2.3B₩2B₩432M₩889M₩310M
Free cash flow−₩271M−₩2.2B−₩1.4B−₩391M−₩3.3B−₩1.5B−₩322M₩539M

Consolidated where available. Amounts in won.

Also known as: HLB Pharmaceutical / HLB제약 / 047920 / KRX:047920

Source: KRX statistical information